Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

Richard Paul Green,1 Kenneth Blum,2– 5 Kai Uwe Lewandrowski,5,6 Mark S Gold,7 Alexander PL Lewandrowski,8 Panayotis K Thanos,2,9 Catherine A Dennen,10 David Baron,3,11 Igor Elman,2,12 Alireza Sharafshah,13 Edward J Modestino,14 Rajendra D Badgaiyan15 1Precision Translational Medicine, LLC, San Anton...

Full description

Saved in:
Bibliographic Details
Main Authors: Green RP, Blum K, Lewandrowski KU, Gold MS, Lewandrowski AP, Thanos PK, Dennen CA, Baron D, Elman I, Sharafshah A, Modestino EJ, Badgaiyan RD
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Substance Abuse and Rehabilitation
Subjects:
reward deficiency syndrome
genetic addiction risk score (gars)
substance use disorders (suds)
dopamine
samhsa
Online Access:https://www.dovepress.com/response-to-the-samhsa-clinical-advisory-considerations-for-genetic-te-peer-reviewed-fulltext-article-SAR
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/response-to-the-samhsa-clinical-advisory-considerations-for-genetic-te-peer-reviewed-fulltext-article-SAR

Similar Items